Answer
Non-melanoma skin cancer has been reported with topical JAK inhibitors. Periodic examination of the application site is recommended, especially when risk factors are present.
Sources for this answer
- Anzupgo 20 mg/g cream — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.